Journal of Clinical Oncology, Vol 15, 2701-2708, Copyright © 1997 by American Society of Clinical Oncology

ARTICLES

Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow

A Zippelius, P Kufer, G Honold, MW Kollermann, R Oberneder, G Schlimok, G Riethmuller and K Pantel
Institut fur Immunologie der Universitat Munchen, Germany.

PURPOSE: This study was designed to evaluate the potential of reverse- transcriptase polymerase chain reaction (RT-PCR) analyses for the detection of micrometastatic carcinoma cells in bone marrow (BM). PATIENTS AND METHODS: The specificity of RT-PCR assays with primers specific for various tumor-associated and organ-specific mRNA species was examined by analysis of 53 BM aspirates from control patients with no epithelial malignancy. In addition, BM samples from 63 patients with prostate cancer (n = 53) or breast cancer (n = 10) were analyzed by RT- PCR with primers specific for prostate-specific antigen (PSA) mRNA. As a reference method, all samples were analyzed simultaneously by an established immunocytochemical assay, using monoclonal antibodies (mAbs) against cytokeratins (CK) for tumor-cell detection. RESULTS: Seven of eight marker species could be detected in a considerable number of BM samples from control patients: epithelial glycoprotein-40 (EGP-40; 53 of 53 samples), desmoplakin I (DPI I; five of five), carcinoembryonic antigen (CEA; five of 19), erb-B2 (five of seven), erb- B3 (six of seven), prostate-specific membrane antigen (PSM; four of nine), and CK18 (five of seven). Only PSA mRNA was not detected in any of the 53 control BM samples. In serial dilution experiments, the PSA RT-PCR assay was able to detect five LNCaP prostate carcinoma cells in 4 x 10(6) BM cells. CK-positive cells were found in 20 patients (37.7%) with prostate cancer, while PSA mRNA was found in only 15 (28.3%; P = .04). Moreover, despite the recent observation that PSA is also expressed in mammary carcinomas, none of the 10 CK-positive BM samples were PSA mRNA-positive. CONCLUSION: Limiting factors in the detection of micrometastatic tumor cells by RT-PCR are (1) the illegitimate transcription of tumor-associated or epithelial-specific genes in hematopoietic cells, and (2) the deficient expression of the marker gene in micrometastatic tumor cells.

This article has been cited by other articles:

				C. Alix-Panabieres, S. Riethdorf, and K. Pantel Circulating Tumor Cells and Bone Marrow Micrometastasis Clin. Cancer Res., August 15, 2008; 14(16): 5013 - 5021. [Abstract] [Full Text] [PDF]

				K. Pantel, C. Alix-Panabieres, and S. Riethdorf Circulating Tumor Cells: Detection and Clinical Relevance Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 603 - 610. [Abstract] [Full Text] [PDF]

				S. Riethdorf, H. Fritsche, V. Muller, T. Rau, C. Schindlbeck, B. Rack, W. Janni, C. Coith, K. Beck, F. Janicke, et al. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System Clin. Cancer Res., February 1, 2007; 13(3): 920 - 928. [Abstract] [Full Text] [PDF]

				W. Janni, B. Rack, K. Lindemann, and N. Harbeck Detection of Micrometastatic Disease in Bone Marrow: Is It Ready for Prime Time? Oncologist, August 1, 2005; 10(7): 480 - 492. [Abstract] [Full Text] [PDF]

				X. T. Wang, W. Sienel, S. Eggeling, C. Ludwig, E. Stoelben, J. Mueller, C. A. Klein, and B. Passlick Detection of disseminated tumor cells in mediastinoscopic lymph node biopsies and lymphadenectomy specimens of patients with NSCLC by quantitative RT-PCR Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 26 - 32. [Abstract] [Full Text] [PDF]

				M. M. Reinholz, A. Nibbe, L. M. Jonart, K. Kitzmann, V. J. Suman, J. N. Ingle, R. Houghton, B. Zehentner, P. C. Roche, and W. L. Lingle Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast Cancer Clin. Cancer Res., May 15, 2005; 11(10): 3722 - 3732. [Abstract] [Full Text] [PDF]

				S. Braun and B. Naume Circulating and Disseminated Tumor Cells J. Clin. Oncol., March 10, 2005; 23(8): 1623 - 1626. [Full Text] [PDF]

				M. B. Wallace, M. I. Block, W. Gillanders, J. Ravenel, B. J. Hoffman, C. E. Reed, M. Fraig, D. Cole, and M. Mitas Accurate Molecular Detection of Non-small Cell Lung Cancer Metastases in Mediastinal Lymph Nodes Sampled by Endoscopic Ultrasound-Guided Needle Aspiration Chest, February 1, 2005; 127(2): 430 - 437. [Abstract] [Full Text] [PDF]

				V Choesmel, F Foucault, J P Thiery, and N Blin Design of a real time quantitative PCR assay to assess global mRNA amplification of small size specimens for microarray hybridisation J. Clin. Pathol., December 1, 2004; 57(12): 1278 - 1287. [Abstract] [Full Text] [PDF]

				S. B. Ho, A. Hyslop, R. Albrecht, A. Jacobson, M. Spencer, D. A. Rothenberger, G. A. Niehans, J. D'Cunha, and R. A. Kratzke Quantification of Colorectal Cancer Micrometastases in Lymph Nodes by Nested and Real-Time Reverse Transcriptase-PCR Analysis for Carcinoembryonic Antigen Clin. Cancer Res., September 1, 2004; 10(17): 5777 - 5784. [Abstract] [Full Text] [PDF]

				D. B. Seligson, A. J. Pantuck, X. Liu, Y. Huang, S. Horvath, M. H. T. Bui, K.-r. Han, A. J. L. Correa, M. Eeva, S. Tze, et al. Epithelial Cell Adhesion Molecule (KSA) Expression: Pathobiology and Its Role as an Independent Predictor of Survival in Renal Cell Carcinoma Clin. Cancer Res., April 15, 2004; 10(8): 2659 - 2669. [Abstract] [Full Text] [PDF]

				J.-Y. Pierga, C. Bonneton, A. Vincent-Salomon, P. de Cremoux, C. Nos, N. Blin, P. Pouillart, J.-P. Thiery, and H. Magdelenat Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients Clin. Cancer Res., February 15, 2004; 10(4): 1392 - 1400. [Abstract] [Full Text] [PDF]

				K. Pantel, V. Muller, M. Auer, N. Nusser, N. Harbeck, and S. Braun Detection and Clinical Implications of Early Systemic Tumor Cell Dissemination in Breast Cancer Clin. Cancer Res., December 15, 2003; 9(17): 6326 - 6334. [Abstract] [Full Text] [PDF]

				B. Taback, A. E. Giuliano, N. M. Hansen, F. R. Singer, S. Shu, and D. S. B. Hoon Detection of Tumor-Specific Genetic Alterations in Bone Marrow from Early-Stage Breast Cancer Patients Cancer Res., April 15, 2003; 63(8): 1884 - 1887. [Abstract] [Full Text] [PDF]

				W. Sienel, R. Seen-Hibler, W. Mutschler, K. Pantel, and B. Passlick Tumour cells in the tumour draining vein of patients with non-small cell lung cancer: detection rate and clinical significance Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 451 - 456. [Abstract] [Full Text] [PDF]

				S. F. Shariat, M. W. Kattan, S. Erdamar, C. Nguyen, P. T. Scardino, D. M. Spencer, T. M. Wheeler, and K. M. Slawin Detection of Clinically Significant, Occult Prostate Cancer Metastases in Lymph Nodes Using a Splice Variant-Specific RT-PCR Assay for Human Glandular Kallikrein J. Clin. Oncol., April 1, 2003; 21(7): 1223 - 1231. [Abstract] [Full Text] [PDF]

				S. F. Shariat, E. Gottenger, C. Nguyen, W. Song, M. W. Kattan, J. Andenoro, T. M. Wheeler, D. M. Spencer, and K. M. Slawin Preoperative Blood Reverse Transcriptase-PCR Assays for Prostate-specific Antigen and Human Glandular Kallikrein for Prediction of Prostate Cancer Progression after Radical Prostatectomy Cancer Res., October 15, 2002; 62(20): 5974 - 5979. [Abstract] [Full Text] [PDF]

				T. Fehm, A. Sagalowsky, E. Clifford, P. Beitsch, H. Saboorian, D. Euhus, S. Meng, L. Morrison, T. Tucker, N. Lane, et al. Cytogenetic Evidence That Circulating Epithelial Cells in Patients with Carcinoma Are Malignant Clin. Cancer Res., July 1, 2002; 8(7): 2073 - 2084. [Abstract] [Full Text] [PDF]

				F A Vlems, J H S Diepstra, I M H A Cornelissen, T J M Ruers, M J L Ligtenberg, C J A Punt, J H J M van Krieken, T. Wobbes, and G N P van Muijen Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue Mol. Pathol., June 1, 2002; 55(3): 156 - 163. [Abstract] [Full Text] [PDF]

				N. Hara, T. Kasahara, T. Kawasaki, V. Bilim, K. Obara, K. Takahashi, and Y. Tomita Reverse Transcription-Polymerase Chain Reaction Detection of Prostate-specific Antigen, Prostate-specific Membrane Antigen, and Prostate Stem Cell Antigen in One Milliliter of Peripheral Blood: Value for the Staging of Prostate Cancer Clin. Cancer Res., June 1, 2002; 8(6): 1794 - 1799. [Abstract] [Full Text] [PDF]

				A. J. Bosma, B. Weigelt, A. C. Lambrechts, O. J. H. M. Verhagen, R. Pruntel, A. A. M. Hart, S. Rodenhuis, and L. J. v.'t Veer Detection of Circulating Breast Tumor Cells by Differential Expression of Marker Genes Clin. Cancer Res., June 1, 2002; 8(6): 1871 - 1877. [Abstract] [Full Text] [PDF]

				M P G Leers, R H M G Schoffelen, J G M Hoop, P H M H Theunissen, J W A Oosterhuis, H v. Bijl, A Rahmy, W Tan, and M Nap Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer J. Clin. Pathol., May 1, 2002; 55(5): 359 - 366. [Abstract] [Full Text] [PDF]

				S. A. Ahrendt, S. C. Yang, L. Wu, C. M. Roig, P. Russell, W. H. Westra, J. Jen, M. V. Brock, R. F. Heitmiller, and D. Sidransky Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: Preliminary results of a prospective study J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 466 - 474. [Abstract] [Full Text] [PDF]

				A. L. Silva, M. J. Tome, A. E. Correia, and J. L. Passos-Coelho Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products Ann. Onc., March 1, 2002; 13(3): 422 - 429. [Abstract] [Full Text] [PDF]

				P. Kufer, A. Zippelius, R. Lutterbuse, I. Mecklenburg, T. Enzmann, A. Montag, D. Weckermann, B. Passlick, N. Prang, P. Reichardt, et al. Heterogeneous Expression of MAGE-A Genes in Occult Disseminated Tumor Cells: A Novel Multimarker Reverse Transcription-Polymerase Chain Reaction for Diagnosis of Micrometastatic Disease Cancer Res., January 1, 2002; 62(1): 251 - 261. [Abstract] [Full Text] [PDF]

				T. A. Fava, R. Desnoyers, S. Schulz, J. Park, D. Weinberg, E. Mitchell, and S. A. Waldman Ectopic Expression of Guanylyl Cyclase C in CD34+ Progenitor Cells in Peripheral Blood J. Clin. Oncol., October 1, 2001; 19(19): 3951 - 3959. [Abstract] [Full Text]

				K. C. Redmond, J. H. Wang, K. K. Austin, N. Relihan, G. McGreal, W. O. Kirwan, D. Richardson, J. Kelly, H. P. Redmond, S. Braun, et al. Is Immunohistochemical Analysis an Appropriate Diagnostic Technique for Bone Marrow Micrometastases? J. Clin. Oncol., August 1, 2001; 19(15): 3589 - 3592. [Full Text]

				Y.-W. Tien, K.-J. Chang, Y.-M. Jeng, P.-H. Lee, M.-S. Wu, J.-T. Lin, and S.-M. Hsu Tumor Angiogenesis and Its Possible Role in Intravasation of Colorectal Epithelial Cells Clin. Cancer Res., June 1, 2001; 7(6): 1627 - 1632. [Abstract] [Full Text] [PDF]

				S. Braun, G. Schlimok, I. Heumos, G. Schaller, L. Riethdorf, G. Riethmüller, and K. Pantel erbB2 Overexpression on Occult Metastatic Cells in Bone Marrow Predicts Poor Clinical Outcome of Stage I-III Breast Cancer Patients Cancer Res., March 1, 2001; 61(5): 1890 - 1895. [Abstract] [Full Text]

				P. Gazzaniga, O. Gandini, L. Giuliani, M. Magnanti, A. Gradilone, I. Silvestri, W. Gianni, M. Gallucci, L. Frati, and A. M. Aglianò Detection of Epidermal Growth Factor Receptor mRNA in Peripheral Blood: A New Marker of Circulating Neoplastic Cells in Bladder Cancer Patients Clin. Cancer Res., March 1, 2001; 7(3): 577 - 583. [Abstract] [Full Text]

				B. Gerber, A. Krause, H. Muller, D. Richter, T. Reimer, J. Makovitzky, C. Herrnring, U. Jeschke, G. Kundt, and K. Friese Simultaneous Immunohistochemical Detection of Tumor Cells in Lymph Nodes and Bone Marrow Aspirates in Breast Cancer and Its Correlation With Other Prognostic Factors J. Clin. Oncol., February 15, 2001; 19(4): 960 - 971. [Abstract] [Full Text] [PDF]

				S. Hosch, J. Kraus, P. Scheunemann, J. R. Izbicki, C. Schneider, U. Schumacher, K. Witter, M. R. Speicher, and K. Pantel Malignant Potential and Cytogenetic Characteristics of Occult Disseminated Tumor Cells in Esophageal Cancer Cancer Res., December 1, 2000; 60(24): 6836 - 6840. [Abstract] [Full Text]

				T. Majima, T. Ichikura, E. Takayama, K. Chochi, and H. Mochizuki Detecting Circulating Cancer Cells Using Reverse Transcriptase-Polymerase Chain Reaction for Cytokeratin mRNA in Peripheral Blood from Patients with Gastric Cancer Jpn. J. Clin. Oncol., November 1, 2000; 30(11): 499 - 503. [Abstract] [Full Text] [PDF]

				V. M. M. van Houten, M. P. Tabor, M. W. M. van den Brekel, F. Denkers, R. G. A. Wishaupt, J. A. Kummer, G. B. Snow, and R. H. Brakenhoff Molecular Assays for the Diagnosis of Minimal Residual Head-and-Neck Cancer: Methods, Reliability, Pitfalls, and Solutions Clin. Cancer Res., October 1, 2000; 6(10): 3803 - 3816. [Abstract] [Full Text]

				K. D. Bauer, Jose de la Torre-Bueno, I. J. Diel, D. Hawes, W. J. Decker, C. Priddy, B. Bossy, S. Ludmann, K. Yamamoto, A. S. Masih, et al. Reliable and Sensitive Analysis of Occult Bone Marrow Metastases Using Automated Cellular Imaging Clin. Cancer Res., September 1, 2000; 6(9): 3552 - 3559. [Abstract] [Full Text]

				P. de Cremoux, J. M. Extra, M. G. Denis, J. Y. Pierga, E. Bourstyn, C. Nos, K. B. Clough, E. Boudou, E. C. Martin, A. Müller, et al. Detection of MUC1-expressing Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients by Real-Time Polymerase Chain Reaction Clin. Cancer Res., August 1, 2000; 6(8): 3117 - 3122. [Abstract] [Full Text]

				A. Zippelius, R. Lutterbüse, G. Riethmüller, and K. Pantel Analytical Variables of Reverse Transcription-Polymerase Chain Reaction-based Detection of Disseminated Prostate Cancer Cells Clin. Cancer Res., July 1, 2000; 6(7): 2741 - 2750. [Abstract] [Full Text]

				R. Sabbatini, M. Federico, M. Morselli, R. Depenni, K. Cagossi, M. Luppi, G. Torelli, and V. Silingardi Detection of Circulating Tumor Cells by Reverse Transcriptase Polymerase Chain Reaction of Maspin in Patients With Breast Cancer Undergoing Conventional-Dose Chemotherapy J. Clin. Oncol., May 9, 2000; 18(9): 1914 - 1920. [Abstract] [Full Text] [PDF]

				B. Cagir, A. Gelmann, J. Park, T. Fava, A. Tankelevitch, E. W. Bittner, E. J. Weaver, J. P. Palazzo, D. Weinberg, R. D. Fry, et al. Guanylyl Cyclase C Messenger RNA Is a Biomarker for Recurrent Stage II Colorectal Cancer Ann Intern Med, December 7, 1999; 131(11): 805 - 812. [Abstract] [Full Text] [PDF]

				B. Passlick, B. Kubuschok, J. R. Izbicki, O. Thetter, and K. Pantel Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer Ann. Thorac. Surg., December 1, 1999; 68(6): 2053 - 2058. [Abstract] [Full Text] [PDF]

				M. V. Fournier, F. C. Guimaraes, M. E. M. Paschoal, L. V. Ronco, M. d. G. C. Carvalho, and A. B. Pardee Identification of a Gene Encoding a Human Oxysterol-binding Protein-Homologue: A Potential General Molecular Marker for Blood Dissemination of Solid Tumors Cancer Res., August 1, 1999; 59(15): 3748 - 3753. [Abstract] [Full Text] [PDF]

				R. A. Ghossein, S. Bhattacharya, and J. Rosai Molecular Detection of Micrometastases and Circulating Tumor Cells in Solid Tumors Clin. Cancer Res., August 1, 1999; 5(8): 1950 - 1960. [Abstract] [Full Text] [PDF]

				K. Pantel, R. J. Cote, and O. Fodstad Detection and Clinical Importance of Micrometastatic Disease J Natl Cancer Inst, July 7, 1999; 91(13): 1113 - 1124. [Abstract] [Full Text] [PDF]

				O. Zach, H. Kasparu, O. Krieger, W. Hehenwarter, M. Girschikofsky, and D. Lutz Detection of Circulating Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients Via a Nested Reverse Transcriptase Polymerase Chain Reaction Assay for Mammaglobin mRNA J. Clin. Oncol., July 1, 1999; 17(7): 2015 - 2015. [Abstract] [Full Text] [PDF]

				F. Mannello, S. Barulli, M. Malatesta, S. Mancini, P. Leoni, and G. Gazzanelli Prostate-specific Antigen Expression in Normal Human Bone Marrow Cells Clin. Chem., July 1, 1999; 45(7): 1102 - 1103. [Full Text] [PDF]

				R. H. Brakenhoff, J. G. W. Stroomer, C. t. Brink, R. de Bree, S. M. Weima, G. B. Snow, and G. A. M. S. van Dongen Sensitive Detection of Squamous Cells in Bone Marrow and Blood of Head and Neck Cancer Patients by E48 Reverse Transcriptase-Polymerase Chain Reaction Clin. Cancer Res., April 1, 1999; 5(4): 725 - 732. [Abstract] [Full Text] [PDF]

				M. J. Slade, B. M. Smith, H. D. Sinnett, N. C.P. Cross, and R. C. Coombes Quantitative Polymerase Chain Reaction for the Detection of Micrometastases in Patients With Breast Cancer J. Clin. Oncol., March 1, 1999; 17(3): 870 - 870. [Abstract] [Full Text] [PDF]

				W. Dietmaier, A. Hartmann, S. Wallinger, E. Heinmoller, T. Kerner, E. Endl, K.-W. Jauch, F. Hofstadter, and J. Ruschoff Multiple Mutation Analyses in Single Tumor Cells with Improved Whole Genome Amplification Am. J. Pathol., January 1, 1999; 154(1): 83 - 95. [Abstract] [Full Text] [PDF]

				A. E.H. Merrie, K. Yun, J. L. McCall, R. A. Ghossein, P. J. Bostick, D. S.B. Hoon, R. J. Cote, G.-J. Liefers, A.-M. Cleton-Jansen, and R. A.E.M. Tollenaar Detection of Carcinoembryonic Antigen Messenger RNA in Lymph Nodes from Patients with Colorectal Cancer N. Engl. J. Med., November 26, 1998; 339(22): 1642 - 1644. [Full Text]

				F. Mannello, F. Luchetti, D. Lancioli, S. Battistelli, S. Papa, and G. Gazzanelli Prostate-specific Antigen Expression in Neoplastic Human Myeloid Cell Lines Clin. Chem., September 1, 1998; 44(9): 1991 - 1993. [Full Text] [PDF]

				D. Sidransky Nucleic Acid-Based Methods for the Detection of Cancer Science, November 7, 1997; 278(5340): 1054 - 1058. [Abstract] [Full Text]